Digital fetal scalp stimulation (dFSS) versus fetal blood sampling (FBS) to assess fetal wellbeing in labour-a multi-centre randomised controlled trial: Fetal Intrapartum Randomised Scalp Stimulation Trial (FIRSST NCT05306756)

D J Murphy, Y Shahabuddin, S Yambasu, K O'Donoghue, D Devane, A Cotter, G Gaffney, L A Burke, E J Molloy, F Boland, D J Murphy, Y Shahabuddin, S Yambasu, K O'Donoghue, D Devane, A Cotter, G Gaffney, L A Burke, E J Molloy, F Boland

Abstract

Background: Cardiotocography (CTG) is a screening test used to detect fetal hypoxia in labour. It has a high false positive rate resulting in many potentially unnecessary caesarean sections. Fetal blood sampling (FBS) is a second-line test of the acid-base status of the fetus. It is used to provide either reassurance that it is safe for labour to continue or objective evidence of compromise so that delivery can be expedited. Digital fetal scalp stimulation (dFSS) to elicit a fetal heart rate acceleration is an alternative less invasive second-line test of fetal wellbeing. This study aims to provide robust evidence on the role of these two second-line tests in assessing fetal wellbeing and potentially preventing operative delivery.

Methods: A multi-centre parallel group randomised controlled trial (RCT) is planned in four maternity centres in Ireland. The study aims to recruit 2500 nulliparous women with a term (≥37+0 weeks) singleton pregnancy who require a second-line test of fetal wellbeing in labour due to an abnormal CTG. Women will be allocated randomly to dFSS or FBS on a 1:1 ratio. The primary outcome is caesarean section. With 1250 women in each arm, the study will have 90% power to detect a difference of 5-6%, at a two-sided alpha significance level of 5%, assuming a caesarean section rate of at least 20% in the dFSS group.

Discussion: If the proposed study shows evidence that dFSS is a safe, reliable and effective alternative to FBS, this would have ground-breaking implications for labour management worldwide. It could potentially lead to a reduction in invasive procedures and emergency caesarean sections.

Trial registration: ClinicalTrials.gov NCT05306756. Registered on 31 March 2022. The trial commenced enrolment on 10 May 2022. Ethical committee approval has been granted by the Research Ethics Committee (REC) of each hospital: Dublin/CWIUH REC: 12.06.2019; Cork/UCC REC: 29.11.2019; Galway/NUIG REC: 06.09.2019; Limerick/UL REC: 30.09.2019.

Keywords: Caesarean section; Cardiotocography; Digital fetal scalp stimulation (dFSS); Fetal blood sampling (FBS); Labour; Randomised controlled trial.

Conflict of interest statement

DJM provides medico-legal expert opinion including aspects of CTG interpretation and second-line testing.

No other competing interests to declare.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
FIRSST trial schedule of enrolment, interventions and assessments
Fig. 2
Fig. 2
CONSORT flow diagram of the FIRSST trial

References

    1. Alfirevic Z, Devane D, Gyte GM, Cuthbert A. Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane Database Syst Rev. 2017;2(2):CD006066. doi: 10.1002/14651858.CD006066.pub3.
    1. Nelson KB, Dambrosia JM, Ting TY, Grether JK. Uncertain value of electronic fetal monitoring in predicting cerebral palsy. N Engl J Med. 1996;334(10):613–618. doi: 10.1056/NEJM199603073341001.
    1. Neilson JP. Fetal scalp sampling in labour. BMJ. 2008;336(7657):1257–1258. doi: 10.1136/bmj.39567.480972.80.
    1. National Institute for Health and Clinical Excellence . Intrapartum care, clinical guideline. London: National Institute for Health and Clinical Excellence; 2017.
    1. ACOG Practice bulletin Number 106 Intrapartum fetal heart rate monitoring: nomenclature, interpretation and general management principles. Obstet Gynecol. 2009;114(1):192–202. doi: 10.1097/AOG.0b013e3181aef106.
    1. Annappa R, Campbell DJ, Simpson NA. Fetal blood sampling in labour and the decision to delivery interval. Eur J Obstet Gynecol Reprod Biol. 2008;141(1):10–12. doi: 10.1016/j.ejogrb.2008.07.002.
    1. Skupski DW, Rosenberg CR, Eglinton GS. Intrapartum fetal stimulation tests: a meta-analysis. Obstet Gynecol. 2002;99(1):129–134.
    1. Mahendru AA, Lees CC. Is intrapartum fetal blood sampling a gold standard diagnostic tool for fetal distress? Eur J Obstet Gynecol Reprod Biol. 2011;156:137–139. doi: 10.1016/j.ejogrb.2010.12.044.
    1. Tuffnell D, Haw WL, Wilkinson K. How long does a fetal scalp blood sample take? BJOG. 2006;113(3):332–334. doi: 10.1111/j.1471-0528.2006.00859.x.
    1. O’Brien YM, Murphy DJ. The reliability of foetal blood sampling as a test of foetal acidosis in labour. Eur J Obstet Gynecol Reprod Biol. 2013;167(2):142–145. doi: 10.1016/j.ejogrb.2012.11.016.
    1. Chandraharan E. Fetal blood sampling during labour: is it a useful diagnostic test or a historical test that no longer has a place in modern clinical obstetrics? BJOG. 2014;121(9):1056–1060. doi: 10.1111/1471-0528.12614.
    1. HSE National Women and Infants Health Programme. on behalf of the Fetal Heart Rate Monitoring Working Group . National clinical guideline for fetal heart rate monitoring. Dublin: Health Service Executive; 2019.
    1. Tahir Mahmood U, O’Gorman C, Marchocki Z, O’Brien Y, Murphy DJ. Fetal scalp stimulation (FSS) versus fetal blood sampling (FBS) for women with abnormal fetal heart rate monitoring in labor: a prospective cohort study. J Matern Fetal Neonatal Med. 2018;31(13):1742–1747. doi: 10.1080/14767058.2017.1326900.
    1. Hughes O, Murphy DJ. Comparing second-line tests to assess fetal wellbeing in labor: a feasibility study and pilot randomized controlled trial. J Matern Fetal Neonatal Med. 2022;35(1):91–99. doi: 10.1080/14767058.2020.1712704.
    1. Murphy DJ, Devane D, Molloy E. Fetal scalp stimulation for assessing fetal wellbeing during labour. Cochrane Database Syst Rev. 2020;(12). 10.1002/14651858.CD01380.
    1. Tahmina S, Daniel M, Krishnan L. Role of manual fetal stimulation during fetal monitoring in labor [Manual fetal stimulation during intrapartum fetal surveillance - a randomized controlled trial.] Am J Obstet Gynecol MFM. 2022;4(2):100574. doi: 10.1016/j.ajogmf.2022.100574.

Source: PubMed

3
구독하다